7 Million Tokens Sells Out in less than One Hour--$MBG Token Pre-Sale Shatters Expectations
HONG KONG — MultiBank Group, the world's largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group's $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap.
Article content
The $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io & Uniswap.Following thousands of additional requests, MultiBank Group will open a final $MBG Token Pre-Sale on Friday July 18.
Article content
Priced at $0.35 per token, the entire allocation was claimed almost instantly. This exceptional level of interest marks one of the most successful offerings in the digital asset space this year, highlighting intense demand for asset-backed products with real-world utility.
Article content
Following thousands of additional requests, MultiBank Group will open a second and final $MBG Token Pre-Sale on Friday 18th of July, ahead of the official Token Generation Event (TGE) on July 22. This last round will feature 3 million tokens at the exclusive price of $0.35, giving early participants one last chance to join before trading begins. The final $MBG Token Pre-Sale will be available through multibank.io and Uniswap.
Article content
Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: 'The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting the experience, resources, and global reach that underpin everything we do at MultiBank Group. The market has spoken, and it has spoken with speed and conviction.'
Article content
Supported by $29 billion in assets across the group's 4 Pillars and powered by over $35 billion in daily turnover, $MBG token is engineered for substance showcasing the proven track record and compliance of one of the industry's most trusted names.
Article content
MultiBank Group's ecosystem is designed for resilience and growth, anchored by four pillars:
Article content
MultiBank TradFi: A global CFD leader, generating $362 million in revenue in 2024.
MEX Exchange: A $23.7 billion institutional-grade marketplace launching later this year.
MultiBank.io RWA: Bringing $3 billion in tokenized ultra-luxury real estate to market.
MultiBank.io: Expanding into crypto derivatives alongside the sale.
Article content
Together, these platforms will drive a $440 million buyback and burn initiative, reinforcing demand, ensuring a deflationary supply, and sustaining value growth for $MBG holders.
Article content
ABOUT MULTIBANK GROUP
Article content
MultiBank Group, established in California, USA in 2005, is a global leader in financial derivatives. With over 2 million clients in 100+ countries and a daily trading volume exceeding $35 billion, it offers a broad range of brokerage and asset management services. Renowned for innovative trading solutions, robust regulatory compliance, and exceptional customer service, the Group is regulated by 17+ top-tier financial authorities across five continents. Its award-winning platforms provide up to 500:1 leverage across Forex, Metals, Shares, Commodities, Indices, and Cryptocurrencies. MultiBank Group has received over 80 international awards for trading excellence and regulatory compliance. For more information, visit MultiBank Group's website.
Article content
Article content
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
9 hours ago
- Globe and Mail
Citizens JMP Sticks to Its Buy Rating for Amazon (AMZN)
In a report released today, Andrew Boone from Citizens JMP reiterated a Buy rating on Amazon, with a price target of $285.00. The company's shares closed yesterday at $223.88. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Boone is a 5-star analyst with an average return of 10.7% and a 55.02% success rate. Boone covers the Communication Services sector, focusing on stocks such as Meta Platforms, DoorDash, and Alphabet Class A. Currently, the analyst consensus on Amazon is a Strong Buy with an average price target of $251.44, representing a 12.31% upside. In a report released yesterday, Bernstein also maintained a Buy rating on the stock with a $235.00 price target. AMZN market cap is currently $2369.5B and has a P/E ratio of 36.51.
Globe and Mail
12 hours ago
- Globe and Mail
3 Top Growth Stocks to Buy in the Second Half of 2025
Key Points Alibaba is a Chinese AI stock that's dirt cheap. Meta Platforms is making a huge bet on AI that should pay off handsomely. Vertex Pharmaceuticals is expanding into new indications. 10 stocks we like better than Vertex Pharmaceuticals › For decades, Jim McKay introduced ABC's Wide World of Sports with a memorable phrase, "The thrill of victory, and the agony of defeat." McKay's words could apply to many investors in the first half of this year. There have been periods of victory -- and periods of defeat. Of course, the level of victory and defeat investors experienced depended on which stocks they owned. If you want greater chances of winning going forward, the stocks you pick will make a huge difference. Which stocks should you consider? Here are three top growth stocks to buy in the second half of 2025. 1. Alibaba Group Holding Wall Street loves Alibaba Group Holding (NYSE: BABA). Of the 40 analysts surveyed by LSEG in July, 37 rated the stock as a "buy" or a "strong buy." The three outliers recommended holding Alibaba. The consensus 12-month price target reflects an upside potential of roughly 40%. I'm not always on the same page as Wall Street analysts, but I agree with the upbeat views about Alibaba. For one thing, you can't even spell Alibaba without A and I. "Lbaba" just doesn't have the same ring to it. Alibaba is an artificial intelligence (AI) juggernaut in China. Its Alibaba Cloud unit commands 36% of the Chinese cloud infrastructure market, almost twice the market share of its nearest rival. Revenue from Alibaba Cloud's AI-related products has grown by triple-digit percentages for seven consecutive quarters. The company also operates China's leading e-commerce platform. Alibaba's Taobao and Tmall online shopping sites continue to deliver solid revenue growth, and AI is helping improve the user experience on the platforms. But the main reason I like Alibaba is its valuation. The stock trades at a forward earnings multiple of only 10.3. That's dirt cheap for a tech giant that raked in $137.3 billion in revenue and $17.4 billion in profits in its last fiscal year. 2. Meta Platforms Meta Platforms (NASDAQ: META) could be an underappreciated leader in AI. It's not a pure-play AI company like OpenAI. It's not a cloud titan like Amazon (NASDAQ: AMZN), Microsoft (NASDAQ: MSFT), and Alphabet 's (NASDAQ: GOOG)(NASDAQ: GOOGL) Google. However, Meta is making a huge bet on AI that I suspect will pay off handsomely. That wager is already paying off in some ways. For example, AI is helping Meta improve its recommendation models. The company has seen a 5% higher conversion rate on Reels in the latest quarter. Over the last six months, Meta's recommendation system improvements have led to a 7% increase in user time spent on Facebook and 6% on Instagram. More time on these social media apps translates to higher advertising revenue for Meta. AI-powered business messaging presents a tremendous growth opportunity for the company. Businesses in developing nations such as Thailand and Vietnam use Meta's messaging apps heavily to communicate with customers. With AI, this model could be deployed in the U.S. and other major markets. Perhaps the most intriguing arena for Meta, though, is in AI devices. The company is already a leader in smart glasses thanks to its Ray-Ban Meta AI glasses. Its Quest virtual reality headsets remain highly popular with users. I think Meta could be one of the biggest players in a potentially massive AI device market over the next few years. 3. Vertex Pharmaceuticals Not every great growth stock that I recommend buying in the second half of 2025 is focused heavily on AI. Vertex Pharmaceuticals (NASDAQ: VRTX) is a drugmaker with terrific growth prospects. So far in Vertex's history, cystic fibrosis (CF) has been the company's primary focus. That's worked out quite well for the big biotech innovator. Vertex markets the only therapies that treat the underlying cause of CF. Its latest CF drug, Alyftrek, offers the most convenient dosing in its lineup and will almost certainly become a blockbuster quickly. However, Vertex has expanded its horizons to other therapeutic areas. Casgevy, the first approved CRISPR gene-editing therapy, targets two rare blood disorders -- sickle cell disease and transfusion-dependent beta-thalassemia. Earlier this year, Journavx became the first new class of pain medication approved by the U.S. Food and Drug Administration in more than two decades. As a powerful pain drug that isn't an opioid, I expect this new product will become another huge winner for Vertex. And there are potentially more big winners on the way. Vertex's pipeline features three other drugs in late-stage clinical testing. Inaxaplin targets APOL1-mediated kidney disease. Povetacicept's first targeted indication is chronic kidney disease IgA nephropathy. Zimislicel holds the potential to cure severe type 1 diabetes. I like the chances of success for all three programs. Should you invest $1,000 in Vertex Pharmaceuticals right now? Before you buy stock in Vertex Pharmaceuticals, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vertex Pharmaceuticals wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,149!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,060,406!* Now, it's worth noting Stock Advisor's total average return is 1,069% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Keith Speights has positions in Alphabet, Amazon, Meta Platforms, Microsoft, and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Alphabet, Amazon, Meta Platforms, Microsoft, and Vertex Pharmaceuticals. The Motley Fool recommends Alibaba Group and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
Globe and Mail
a day ago
- Globe and Mail
Block Set to Join the S&P 500
Block has been added to the S&P 500, effective July 23, 2025. It's a milestone that reflects the strength of our business and the work of thousands of people building tools to increase access to the economy, across our brands including Square, Cash App, Afterpay, TIDAL, Proto, and Bitkey. Thanks to our customers, teams, and shareholders who've been with us on the journey. We're just getting started. About Block, Inc. Block, Inc. (NYSE: XYZ) builds technology to increase access to the global economy. Each of our brands unlocks different aspects of the economy for more people. Square makes commerce and financial services accessible to sellers. Cash App is the easy way to spend, send, and store money. Afterpay is transforming the way customers manage their spending over time. TIDAL is a music platform that empowers artists to thrive as entrepreneurs. Bitkey is a simple self-custody wallet built for bitcoin. Proto is a suite of bitcoin mining products and services. Together, we're helping build a financial system that is open to everyone.
